BGPT: Paper Review: Three Homologous Subunits Form a High Affinity Peptide-gated Ion Channel in Hydra

Explore by Goal

Quick Explanation Copied

Key claim (and what to doubt)

The paper reports that a third, homologous Hydra DEG/ENaC subunit (HyNaC5) is incorporated with HyNaC2 and HyNaC3 to form a three-subunit peptide-gated channel whose peptide affinity and amiloride sensitivity change substantially versus HyNaC2/3 alone.

Skeptical check: much of the evidence is heterologous (Xenopus oocytes). The native Hydra channel’s exact stoichiometry, membrane context, and in vivo gating mechanism are not directly proven by this work alone.

Long Explanation

Paper Review: Three Homologous Subunits Form a High Affinity Peptide-gated Ion Channel in Hydra

Journal of Biological Chemistry • DOI: 10.1074/jbc.M109.059998 Published: Feb 16, 2010 Focus: HyNaC5 as third subunit (HyNaC2/3/5)

1) Visual evidence map (what was measured → what it supports)

Core measurements include Xenopus oocyte peptide-gated currents, peptide dose–responses, HA-based surface expression comparisons, ion-substitution selectivity, blocker IC50 shifts, and a Hydra feeding delay assay with amiloride.

2) Main result visualizations (raw key numeric anchors from the paper)

The paper reports a ~16-fold increase in peak current amplitude for HyNaC2/3/5 relative to HyNaC2/3, while HyNaC2/3/5 amplitudes often exceeded the amplifier capacity (>50 µA).

Apparent half-maximal activation concentrations reported: RFamide I EC50 = 326 ± 108 µM (HyNaC2/3) vs 4.8 ± 2.0 µM (HyNaC2/3/5); RFamide II EC50 = 38 ± 13 µM vs 0.34 ± 0.08 µM.

The paper reports amiloride IC50 = 540 ± 160 µM for HyNaC2/3 and 122 ± 9 µM for HyNaC2/3/5.

The paper reports: reversal potentials are not significantly different between HyNaC2/3 and HyNaC2/3/5; K+ and Li+ carried inward currents are significantly reduced relative to Na+ currents, with a more prominent reduction for HyNaC2/3/5 than for HyNaC2/3.

3) Mechanistic interpretation with explicit uncertainty boundaries

3.1 Evidence that HyNaC5 improves function more than surface trafficking

The paper uses an HA epitope inserted in an extracellular loop of HyNaC2 and a luminescence-based assay to compare relative surface expression of tagged HyNaC2 in HyNaC2/3 and HyNaC2/3/5 coexpressions. Surface expression for HyNaC2/3/5 is not significantly different from HyNaC2/3, while both are substantially higher than HyNaC2 alone. The authors argue that this cannot explain the ~16-fold current increase solely via altered trafficking, implying increased current through surface-expressed channels (e.g., higher open probability or single-channel conductance).

Uncertainty: the HA-surface readout assumes how many subunits are tagged per channel and the native stoichiometry. The paper itself notes that depending on stoichiometry (e.g., 2/2/3 channel variants), the assay could underestimate certain configurations by up to a factor of ~2, but that still would not fully explain the current increase.

3.2 Why “high-affinity” is supported (and what “apparent” means)

The paper reports large shifts in peptide concentration–response curves for RFamide I and RFamide II when HyNaC5 is coexpressed with HyNaC2 and HyNaC3, with Hill coefficients reported as similar between the conditions. Because these values are fit from functional activation curves in a heterologous system, the authors’ “affinity” language is appropriately operational (“apparent” EC50 from current activation), not a direct biophysical binding constant in the paper’s assay.

3.3 Pore and blocker logic: amiloride sensitivity is consistent with pore contribution

The paper shows that amiloride inhibition curves shift strongly when HyNaC5 is present (IC50 decreases ~4–5×). It also notes that Hydra-RFamides do not strongly compete with amiloride under their test conditions and that amiloride analogs (benzamil, phenamil) block more current in the HyNaC2/3/5 condition than in HyNaC2/3. Together with altered ion selectivity, the authors interpret this as HyNaC5 contributing to pore and/or blocker interaction properties.

4) Hydra behavior assay: what the data do and do not establish

The paper reports that in Hydra, amiloride at 100 µM delays the initiation of glutathione-induced tentacle movement (with p < 0.05 at the reported significant time point; at 1:00, p = 0.06), and that the effect is reversible when animals are returned to amiloride-free medium. The authors interpret this as consistent with importance of an amiloride-sensitive ion channel for coordinated feeding reflexes.

Critical limitation: amiloride is not specific to HyNaC2/3/5; the assay demonstrates an amiloride-sensitive aspect of the feeding response, not direct causal necessity of hynac5 or HyNaC2/3/5. The paper itself frames the result as suggestive, and notes that further electrophysiological characterization of the endogenous channel and localization by immunocytochemistry are needed to connect the heterologous channel to the native physiological endpoint.

5) Critical review (skeptical, evidence-weighted)

Strengths

Consistent multi-assay coherence: peptide activation potency increases dramatically with HyNaC5, while surface expression comparisons do not explain the magnitude—supporting a functional role for HyNaC5 rather than only trafficking.
Pore/blocker logic: altered ion permeation behavior and reduced amiloride IC50 with HyNaC5 are compatible with HyNaC5 contributing to pore properties.
Developmental/locational support: ISH places hynac5 expression at the tentacle base with a gradient consistent with coexpression context.

Limitations / alternative explanations to keep in mind

Heterologous system inference: functional measurements come from Xenopus oocytes. While common for channel biophysics, this does not fully replicate Hydra’s native membrane composition, accessory proteins, and cellular context.
Stoichiometry is argued, not directly measured: the “three subunits” model is supported by analogy to related DEG/ENaC structures and functional behavior (EC50/current changes), but the paper does not provide a direct biochemical stoichiometry proof for Hydra’s native channel complex.
Amiloride behavioral effect is nonspecific: amiloride perturbs an amiloride-sensitive component of feeding reflexes, but the work does not isolate HyNaC2/3/5 as the unique molecular target in vivo.

What would most strongly disprove the main model?

If HyNaC5 is not incorporated into the functional complex in the native channel (or if HyNaC2/3 alone is sufficient in vivo), then the “high-affinity three-subunit channel” interpretation would fail as a causal mechanism.
If peptide affinity shifts were secondary to expression levels, trafficking, or nonstoichiometric assembly artifacts in oocytes (rather than genuine receptor pocket/pore modulation), then “affinity” would not reflect HyNaC5’s role in the ligand-binding/pore architecture. The paper attempts to address trafficking via HA surface expression comparisons, but direct in vivo stoichiometry remains the missing piece.

6) Reproducibility checklist (what the paper provides)

Component	Is described?	Primary uncertainty
HyNaC5 cloning / sequence deposition	Yes (RACE; GenBank FN257513 stated)	Exact primer details not shown in provided text excerpt
ISH localization	Yes (probe sizes and concentration windows stated)	Probe preparation details beyond excerpt
Oocyte electrophysiology	Yes (cRNA coexpression; tachyphylaxis mitigation described)	Hardware/electrophysiology “standard conditions” rely on prior cited methods
Surface expression assay	Yes (HA insertion described; luminescence readout described)	Stoichiometry/tagging assumptions
Pore/blocker experiments	Yes (ion substitution; amiloride/analogs inhibition)	Statistical reporting depends on sample counts per figure
Hydra feeding behavior	Yes (medium conditions; time sampling stated)	Scoring criteria for “moving tentacles” not fully detailed here

Every major methodology section is described in the paper’s experimental procedures portion, including RACE cloning, whole-mount ISH, oocyte expression/electrophysiology and tachyphylaxis mitigation, HA-tag luminescence surface expression, ion substitution for selectivity, amiloride/analogs inhibition, and the Hydra glutathione feeding assay.

Explore related BGPT actions

Feedback:

Updated: April 11, 2026